Final five-year outcomes after implantation of biodegradable polymer-coated biolimus-eluting stents versus durable polymer-coated sirolimus-eluting stents

EuroIntervention 2017;13:1337-1345 published online August 2017. DOI: 10.4244/EIJ-D-17-00434

Lars Jakobsen
Lars Jakobsen1*, MD, PhD; Evald H. Christiansen1, MD, PhD; Michael Maeng1, MD, PhD; Knud N. Hansen2, MD; Steen D. Kristensen1, MD, DMSci; Hans E. Bøtker1, MD, DMSci, PhD; Christian J. Terkelsen1, MD, DMSci, PhD; Svend E. Jensen3, MD, PhD; Bent Raungaard3, MD, PhD; Morten Madsen4, MSc; Jens F. Lassen1, MD, PhD; Lisette O. Jensen2, MD, DMSci, PhD; for the SORT OUT (Scandinavian Organization for Randomized Trials with Clinical Outcome) V investigators
1. Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark; 2. Department of Cardiology, Odense University Hospital, Odense, Denmark; 3. Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark; 4. Department of Clinical Epide

Aims: Our aim was to report the long-term safety and efficacy of the biodegradable polymer-coated biolimus-eluting Nobori stent compared to the durable polymer-coated sirolimus-eluting CY

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

clinical researchin-stent restenosisstent thrombosis
Read next article
Evidence of acute giant cell reaction post bioresorbable vascular scaffold implantation

Latest news